Novo Nordisk A/S (NONOF)
46.86
+0.06
(+0.13%)
USD |
OTCM |
Dec 09, 15:55
Novo Nordisk Market Cap: 208.22B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 878.59B |
| Genmab A/S | 19.03B |
| Ascendis Pharma A/S | 12.02B |
| Evaxion AS | 41.56M |
Market Cap Related Metrics
| PE Ratio | 13.65 |
| PS Ratio | 4.471 |
| PEG Ratio | 1.206 |
| Price to Book Value | 7.786 |
| Price to Free Cash Flow | 22.48 |
| Price | 46.86 |
| Earnings Yield | 7.33% |
| PEGY Ratio | 0.9091 |
| Operating PE Ratio | 10.54 |
| Normalized PE Ratio | 13.65 |